USE OF A NOVEL EMBRYONIC MAMMARY STEM CELL GENE SIGNATURE TO IMPROVE HUMAN BREAST CANCER DIAGNOSTICS AND THERAPEUTIC DECISION MAKING

Salk Institute For Biological Studies, San Diego, California, The

Investigators